Targeting cytokines to treat autoimmunity.
Monoclonal antibodies, small molecules and soluble receptors that target cytokines have revolutionized the treatment of autoimmune and autoinflammatory diseases. The articles that are presented in this special issue of Clinical Immunology analyze the basic science, the clinical implications and the future directions of cytokine targeting in these diseases.